Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia

作者: Irène Baccelli , Yves Gareau , Bernhard Lehnertz , Stéphane Gingras , Jean-François Spinella

DOI: 10.1016/J.CCELL.2019.06.003

关键词:

摘要: Summary To identify therapeutic targets in acute myeloid leukemia (AML), we chemically interrogated 200 sequenced primary specimens. Mubritinib, a known ERBB2 inhibitor, elicited strong anti-leukemic effects in vitro and in vivo. In the context of AML, mubritinib functions through ubiquinone-dependent inhibition electron transport chain (ETC) complex I activity. Resistance to characterized normal CD34+ hematopoietic cells chemotherapy-sensitive AMLs, which displayed transcriptomic hallmarks hypoxia. Conversely, sensitivity correlated with mitochondrial function-related gene expression levels large subset chemotherapy-resistant AMLs oxidative phosphorylation (OXPHOS) hyperactivity. Altogether, our work thus identifies an ETC inhibitor reveals genetic landscape OXPHOS dependency AML.

参考文章(66)
Kirill M. Popov, Yu Zhao, Robert A. Harris, David W. Crabb, Yoshiharu Shimomura, John Hawes, Jerzy Jaskiewicz, Site-directed mutagenesis of phosphorylation sites of the branched chain alpha-ketoacid dehydrogenase complex. Journal of Biological Chemistry. ,vol. 269, pp. 18583- 18587 ,(1994) , 10.1016/S0021-9258(17)32349-9
Lucas B. Sullivan, Dan Y. Gui, Aaron M. Hosios, Lauren N. Bush, Elizaveta Freinkman, Matthew G. Vander Heiden, Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells Cell. ,vol. 162, pp. 552- 563 ,(2015) , 10.1016/J.CELL.2015.07.017
Kıvanç Birsoy, Tim Wang, Walter W. Chen, Elizaveta Freinkman, Monther Abu-Remaileh, David M. Sabatini, An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis Cell. ,vol. 162, pp. 540- 551 ,(2015) , 10.1016/J.CELL.2015.07.016
Christof Fellmann, Thomas Hoffmann, Vaishali Sridhar, Barbara Hopfgartner, Matthias Muhar, Mareike Roth, Dan Yu Lai, Inês A.M. Barbosa, Jung Shick Kwon, Yuanzhe Guan, Nishi Sinha, Johannes Zuber, An Optimized microRNA Backbone for Effective Single-Copy RNAi Cell Reports. ,vol. 5, pp. 1704- 1713 ,(2013) , 10.1016/J.CELREP.2013.11.020
Peter Langfelder, Steve Horvath, WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. ,vol. 9, pp. 559- 559 ,(2008) , 10.1186/1471-2105-9-559
J. Yun, C. Rago, I. Cheong, R. Pagliarini, P. Angenendt, H. Rajagopalan, K. Schmidt, J. K. V. Willson, S. Markowitz, S. Zhou, L. A. Diaz, V. E. Velculescu, C. Lengauer, K. W. Kinzler, B. Vogelstein, N. Papadopoulos, Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells Science. ,vol. 325, pp. 1555- 1559 ,(2009) , 10.1126/SCIENCE.1174229
Tugba Simsek, Fatih Kocabas, Junke Zheng, Ralph J. DeBerardinis, Ahmed I. Mahmoud, Eric N. Olson, Jay W. Schneider, Cheng Cheng Zhang, Hesham A. Sadek, The Distinct Metabolic Profile of Hematopoietic Stem Cells Reflects Their Location in a Hypoxic Niche Cell Stem Cell. ,vol. 7, pp. 380- 390 ,(2010) , 10.1016/J.STEM.2010.07.011
JOJI NAGASAWA, ATSUSHI MIZOKAMI, KIYOSHI KOSHIDA, SEI YOSHIDA, KENICHIRO NAITO, MIKIO NAMIKI, Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo. International Journal of Urology. ,vol. 13, pp. 587- 592 ,(2006) , 10.1111/J.1442-2042.2006.01342.X
I H I M Hollink, Q Feng, A A Danen-van Oorschot, S T C J M Arentsen-Peters, L J Verboon, P Zhang, V de Haas, D Reinhardt, U Creutzig, J Trka, R Pieters, M M van den Heuvel-Eibrink, J Wang, C M Zwaan, Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model. Leukemia. ,vol. 26, pp. 371- 373 ,(2012) , 10.1038/LEU.2011.210